Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Vote In favor of Your Favored Pet Consideration Administration - 2The most effective method to Decisively Plan Your Nursing Profession for the Best Compensation Results
- 3Email Promoting Instruments for Compelling Efforts
- 4The Ascent of Rousing Pioneers Who Formed History
- 5Dominating Monetary Administration: A Bit by bit Manual for Making an Individual Financial plan
- How to watch ‘The Traitors’ U.K. Season 4 premiere today from the U.S.
- Find the Techniques for Powerful Review Propensities: Opening Your Scholarly Potential
- Investigate Business Mastercard Choices for Better Rewards and Rewards
- Merz postpones Norway trip for Belgium talks on frozen Russian assets
- Astronaut on ISS captures spectacular orbital video of zodiacal light, auroras and the Pleiades
- Careful Living: Embracing the Current Second
- The 10 Most Significant Games in History
- Remote Headphones: Upgrade Your Sound Insight
- The Main 15 Applications for Efficiency and Association
